Although high concentration of AKT inhibitor treatment is very effective in inhibiting both the control and MAPK4-overexpressing cancer cell growth, the potential toxicity of AKT inhibitors at high concentrations is predicted to limit their therapeutic potential. The gene discussed is MAPK4; the disease is cancer.